| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/17/2000 | CA2362368A1 Method for altering undesirable immune responses to polypeptides |
| 08/17/2000 | CA2297441A1 Fusion proteins comprising carriers that can induce a dual immune response |
| 08/16/2000 | EP1027450A1 Method of dna shuffling |
| 08/16/2000 | EP1027439A2 Multivalent antigen-binding proteins |
| 08/16/2000 | EP1027437A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3 |
| 08/16/2000 | EP1027070A1 Conjugate heat shock protein-binding peptides |
| 08/16/2000 | EP1027066A1 Soluble mhc complexes and methods of use thereof |
| 08/16/2000 | CN1263598A Antibodies and SCFV immunotoxins specific to imported fire ants, and their application |
| 08/16/2000 | CN1263555A Human TOLL-like receptor proteins, related reagents and methods |
| 08/16/2000 | CN1055500C DNA sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom |
| 08/15/2000 | US6103881 GnRH analogs for destroying gonadotrophs |
| 08/15/2000 | US6103501 Recombinant protein which can be utilized as agonist or antagonist to its native cellular counterparts |
| 08/15/2000 | US6103239 Modified HGP-30 heteroconjugates, compositions and methods of use |
| 08/15/2000 | US6103234 Antibody to an inflammatory cytokine, said inflammatory cytokine comprising a mature macrophage inflammatory protein -2 (mmip-2) |
| 08/10/2000 | WO2000046367A2 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
| 08/10/2000 | WO2000046246A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
| 08/10/2000 | WO2000046240A2 Polypeptides involved in immune response |
| 08/10/2000 | WO2000026251A3 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX |
| 08/10/2000 | WO2000026239A3 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 08/10/2000 | CA2362126A1 B7rp-1 polypeptides |
| 08/10/2000 | CA2360741A1 Protein with cell proliferation and cell division modulating activity and dna encoding such protein |
| 08/09/2000 | EP1026250A1 DNA-constructs of blood clotting factors and P-selectin |
| 08/09/2000 | EP1026244A1 Proteins Capable of Triggering G2/M transition and of Interacting with CDC2- and Cyclin B |
| 08/09/2000 | EP1026240A2 Generation and selection of recombinant varied binding proteins |
| 08/09/2000 | EP1025227A2 Human toll homologues |
| 08/09/2000 | EP1025124A1 Low-toxicity human interferon-alpha analogues |
| 08/09/2000 | EP0640133B1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 08/09/2000 | EP0568645B1 Mixed specificity fusion proteins |
| 08/09/2000 | CN1262689A Isolated dendritic cell membrane protein genes |
| 08/08/2000 | US6100071 Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
| 08/08/2000 | US6100065 Recombinant polypeptide particles with high immunogenicity; comprises portion of pre-s1 peptide and surface antigen peptide |
| 08/08/2000 | US6100041 Human prohormone convertase 4 |
| 08/08/2000 | CA2233144C Arf-p19, a novel regulator of the mammalian cell cycle |
| 08/08/2000 | CA1341082C Method of treating tumor cells by inhibiting growth factor receptor function |
| 08/08/2000 | CA1341074C Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine |
| 08/03/2000 | WO2000044908A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 08/03/2000 | WO2000044903A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof |
| 08/03/2000 | WO2000044899A1 Her-2/neu fusion proteins |
| 08/03/2000 | WO2000044392A2 Identification of specific differentially expressed mycobacterial antigens |
| 08/03/2000 | WO2000024884A3 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
| 08/03/2000 | WO2000014240A3 Attenuated salmonella sp12 mutants as antigen carriers |
| 08/03/2000 | WO2000008051A3 Immunological herpes simplex virus antigens and methods for use thereof |
| 08/03/2000 | CA2361246A1 Identification of specific differentially expressed antigens |
| 08/03/2000 | CA2360374A1 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 08/02/2000 | EP1024192A2 Clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said proteins |
| 08/02/2000 | EP1024191A2 Production of chimeric antibodies from antibody segment repertoires and displayed on phage |
| 08/01/2000 | US6096873 Mitogen polypeptide; for the treatment of nervous system and muscular disorders; anticarcinogenic agents |
| 08/01/2000 | US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics |
| 08/01/2000 | US6096315 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| 08/01/2000 | CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 08/01/2000 | CA1341066C Small peptides which inhibit binding to t-4 receptors and act as immunogens |
| 07/27/2000 | WO2000043780A1 Methods for detecting changes to cellular components |
| 07/27/2000 | WO2000043779A1 Method for identifying the ligands of a receptor capable of being internalized |
| 07/27/2000 | WO2000043435A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 07/27/2000 | WO2000023593A3 Molecular pathogenicide mediated plant disease resistance |
| 07/27/2000 | CA2359213A1 Method for identifying the ligands of a receptor capable of being internalized |
| 07/26/2000 | EP1021537A1 T cell receptor-associated molecules (trams) and methods of use therefor |
| 07/26/2000 | EP1021465A2 Gfp-annexin fusion proteins |
| 07/26/2000 | EP0832134B1 Anti-allergy bispecific molecules |
| 07/25/2000 | US6093808 IκBEGFP constructs, cell lines and methods of use |
| 07/25/2000 | US6093693 B cell activation |
| 07/25/2000 | US6093549 Identifying candidate therapeutic agents which interfere with huntingtin associated protein-1(hap1) and huntingtin binding by contacting these proteins and a compound, determining if the compound diminishes the two proteins from binding |
| 07/25/2000 | CA2010256C Protein anti-cancer agent |
| 07/20/2000 | WO2000042179A2 Complex-forming proteins |
| 07/20/2000 | WO2000042171A1 Compositions isolated from plant cells and their use in the modification of plant cell signaling |
| 07/20/2000 | WO2000042064A1 Peptides for inhibiting hpv e6 proteins |
| 07/20/2000 | WO2000041474A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/20/2000 | WO2000010598B1 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 07/20/2000 | WO2000002902A9 Novel inhibitors of angiogenesis and tumor growth |
| 07/20/2000 | DE19901008A1 Peptide zur Inhibierung von HPV E6-Proteinen Peptides for inhibition of HPV-E6 proteins |
| 07/20/2000 | CA2359843A1 Compositions isolated from plant cells and their use in the modification of plant cell signaling |
| 07/20/2000 | CA2359479A1 Novel complex-forming proteins |
| 07/20/2000 | CA2359365A1 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/19/2000 | EP1019432A1 The ob receptor and methods of diagnosing and treating weight |
| 07/19/2000 | CN1054609C Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor |
| 07/18/2000 | US6090914 CTLA4/CD28Ig hybrid fusion proteins and uses thereof |
| 07/18/2000 | US6090778 Neurturin and related growth factors |
| 07/18/2000 | US6090631 Methods and compositions for screening for presynaptic calcium channel blockers |
| 07/18/2000 | US6090388 Peptide composition for prevention and treatment of HIV infection and immune disorders |
| 07/18/2000 | US6090381 Stimulation of an immune response with antibodies labeled with the . .alpha-galactosyl epitope |
| 07/18/2000 | CA2162689C Immunotoxins comprising gelonin and an antibody |
| 07/18/2000 | CA1341053C Polypeptide and protein derivatives and process for their preparation |
| 07/13/2000 | WO2000040721A1 Monocyte-derived nucleic acids and related compositions and methods |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040615A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
| 07/13/2000 | WO2000040603A2 Production of recombinant monellin using methylotrophic yeast expression system |
| 07/13/2000 | WO2000024897B1 Cell surface molecule-induced macrophage activation |
| 07/13/2000 | WO2000020445A3 Tumor antigens and ctl clones isolated by a novel procedure |
| 07/13/2000 | WO2000017364A3 Cyclin d polynucleotides, polypeptides and uses thereof |
| 07/13/2000 | DE19900743A1 Neue komplexbildende Proteine New complexing proteins |
| 07/13/2000 | CA2753331A1 Soluble receptor br43x2 and methods of using |
| 07/13/2000 | CA2364005A1 Production of recombinant monellin using methylotrophic yeast expression system |
| 07/13/2000 | CA2358562A1 Monocyte-derived nucleic acids and related compositions and methods |
| 07/13/2000 | CA2356401A1 Expression and export of anti-obesity proteins as fc fusion proteins |
| 07/12/2000 | EP1018555A2 Chimeric papilomavirus-like particles |
| 07/12/2000 | EP1018344A2 HLA-restricted hepatitis B virus CTL epitopes |
| 07/12/2000 | EP1017829A2 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain |
| 07/12/2000 | EP1017816A1 Insulin-like polypeptide and uses therefor |
| 07/12/2000 | EP1017715A2 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 07/12/2000 | EP1017410A1 Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds |